Patents by Inventor Stephen L. CONWAY

Stephen L. CONWAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160339074
    Abstract: The present invention is directed to compositions comprising the HCV NS3/4A inhibitor, (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopro-pyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxa-diazacyclononadecino[11,12-b]quinoxaline-8-carboxamide, or a pharmaceutically acceptable salt thererof, an oral absorption enhancing polymer, and, optionally, a surfactant. The present invention is also directed to solid dispersions and pharmaceutical compositions containing or made from these compositions, and the methods for making these solid dispersions and pharmaceutical compositions.
    Type: Application
    Filed: February 3, 2015
    Publication date: November 24, 2016
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Melanie J. Marota, Craig McKelvey, Nicholas Birringer, Jesse Kuiper, Paul A. Harmon, Adam J. Socia, Patrick Jules Marsac, Stephen L. Conway
  • Publication number: 20160166529
    Abstract: The instant invention relates to pharmaceutical compositions comprising cathespin K inhibitors and Vitamin D.
    Type: Application
    Filed: July 7, 2014
    Publication date: June 16, 2016
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Majid MAHJOUR, Decheng MA, Christina Marie BACCI, Julianne Margaret FARABAUGH, Justin MOSER, Lixia CAI, Stephen L. CONWAY